BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36332545)

  • 1. Acinic cell carcinoma of the breast: A comprehensive review.
    Ajkunic A; Skenderi F; Shaker N; Akhtar S; Lamovec J; Gatalica Z; Vranic S
    Breast; 2022 Dec; 66():208-216. PubMed ID: 36332545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are acinic cell carcinomas of the breast and salivary glands distinct diseases?
    Piscuoglio S; Hodi Z; Katabi N; Guerini-Rocco E; Macedo GS; Ng CK; Edelweiss M; De Mattos-Arruda L; Wen HY; Rakha EA; Ellis IO; Rubin BP; Weigelt B; Reis-Filho JS
    Histopathology; 2015 Oct; 67(4):529-37. PubMed ID: 25688711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma?
    Hirokawa M; Sugihara K; Sai T; Monobe Y; Kudo H; Sano N; Sano T
    Histopathology; 2002 Mar; 40(3):223-9. PubMed ID: 11895487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
    Geyer FC; Berman SH; Marchiò C; Burke KA; Guerini-Rocco E; Piscuoglio S; Ng CK; Pareja F; Wen HY; Hodi Z; Schnitt SJ; Rakha EA; Ellis IO; Norton L; Weigelt B; Reis-Filho JS
    Mod Pathol; 2017 Jan; 30(1):69-84. PubMed ID: 27713419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
    Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
    J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
    Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
    Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland-like breast carcinomas: An infrequent disease.
    Sherwell-Cabello S; Maffuz-Aziz A; Ríos-Luna NP; Bautista-Piña V; Rodríguez-Cuevas S
    Pathol Res Pract; 2016 Nov; 212(11):1034-1038. PubMed ID: 27667558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.
    Diegel CR; Cho KR; El-Naggar AK; Williams BO; Lindvall C
    Cancer Res; 2010 Nov; 70(22):9143-52. PubMed ID: 21062985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas.
    Bishop JA; Yonescu R; Batista D; Eisele DW; Westra WH
    Am J Surg Pathol; 2013 Jul; 37(7):1053-7. PubMed ID: 23681074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.
    Cima L; Kaya H; Marchiò C; Nishimura R; Wen HY; Fabbri VP; Foschini MP
    Virchows Arch; 2022 Jan; 480(1):109-126. PubMed ID: 34458945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problematic breast tumors reassessed in light of novel molecular data.
    Pareja F; Weigelt B; Reis-Filho JS
    Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.
    Salem A; Wu Y; Albarracin CT; Middleton LP; Kalhor N; Peng Y; Huang X; Aung PP; Chen H; Sahin AA; Ding Q
    Hum Pathol; 2024 Mar; 145():42-47. PubMed ID: 38262580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype.
    Conlon N; Sadri N; Corben AD; Tan LK
    Hum Pathol; 2016 May; 51():16-24. PubMed ID: 27067778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary acinic cell carcinoma: reappraisal and update.
    Vander Poorten V; Triantafyllou A; Thompson LD; Bishop J; Hauben E; Hunt J; Skalova A; Stenman G; Takes RP; Gnepp DR; Hellquist H; Wenig B; Bell D; Rinaldo A; Ferlito A
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3511-3531. PubMed ID: 26685679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinic cell carcinoma of the breast: review of the literature.
    Limite G; Di Micco R; Esposito E; Sollazzo V; Cervotti M; Pettinato G; Varone V; Benassai G; Amato B; Pilone V; Luglio G; Vitiello A; Hasani A; Liccardo F; Forestieri P
    Int J Surg; 2014; 12 Suppl 1():S35-9. PubMed ID: 24859406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.
    Ripamonti CB; Colombo M; Mondini P; Siranoush M; Peissel B; Bernard L; Radice P; Carcangiu ML
    BMC Cancer; 2013 Feb; 13():46. PubMed ID: 23374397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
    Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
    Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.